bioRxiv Science⌕ Search
Home/Archive/bioRxiv

bioRxiv · 10.1101/2025.10.13.682078

Peripheral Inflammation Limits Serotonin Neuron Signaling Capacity via Serotonergic IL-1R1 to Reduce Neuronal Excitability and Enhance Serotonin Clearance

Gajewski, P. A.·Iwamoto, H.·Tillman, A. N.·Filliben, Z.·Walsh, A. E.·Baganz, N. L.·Robson, M. J.·Zapata, M.·Quan, N.·Blakely, R. D.
View original source ↗Export metadata ↓

Abstract

Neurobehavioral disorders, ranging from depression to schizophrenia, have been found to display immune system alterations. The high incidence of comorbidity of these disorders, particularly depression, with chronic inflammatory conditions suggests shared mechanisms contributing to the manifestation of these conditions. We have previously shown that peripheral modulation of the innate immune system in mice rapidly triggers enhanced serotonin (5-HT) clearance in vivo associated with increased anxiety- and despair-like behaviors that can be suppressed by serotonergic elimination of p38 MAPK. Forebrain-projecting 5-HT synthesizing neurons of the dorsal raphe nucleus (DRN5-HT) play a key role in regulating behaviors related to mood and anxiety and whose perturbations are observed in multiple affective disorders. Here we identify molecular and circuit-level mechanisms that can translate peripheral innate immune system activation into changes in 5-HT signaling capacity. Using whole cell patch clamp recordings from acute midbrain slices, we demonstrate that the proinflammatory cytokine, IL-1{beta}, acts cell autonomously through its receptor, IL-1R1, via the p38 MAPK signaling pathway to rapidly inhibit firing of DRN5-HT neurons. In the dorsal hippocampus, we found that as with acute, peripheral lipopolysaccharide (LPS) administration, local injections of IL-1{beta} rapidly enhance 5-HT clearance as assessed by in vivo chronoamperometry. Like IL-1{beta}, TNF also acts via a serotonergic p38 MAPK dependent pathway to reduce excitability of DRN5-HT neurons. Immunocytochemical studies reveal that, IL-1R1, is nonuniformly expressed by DRN5-HT neurons and is required for LPS-induced inhibition of these cells as detected by cFos activation, with sex-dependent patterns evident. Moreover, we detected both DRN5-HT IL-1R1-dependent and -independent LPS-mediated changes in cFos changes in forbrain projection areas. Our findings support a growing appreciation that serotoninergic neurons contribute to changes in CNS physiology and behavior following peripheral immune activation. More specifically, our studies attest to a functional role of serotonergic IL-1R1 in mediating IL-1{beta} following peripheral innate immune activation, effects likely to arise both from changes in diminished 5-HT neuron excitability and elevated 5-HT clearance.

Explore related subjects

neurosciencePreprint

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Gajewski, P. A., Iwamoto, H., Tillman, A. N., Filliben, Z., Walsh, A. E., Baganz, N. L., Robson, M. J., Zapata, M., Quan, N., Blakely, R. D.. 2025-10-14. Peripheral Inflammation Limits Serotonin Neuron Signaling Capacity via Serotonergic IL-1R1 to Reduce Neuronal Excitability and Enhance Serotonin Clearance. https://doi.org/10.1101/2025.10.13.682078

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

bioRxiv2026

The Unreasonable Effectiveness of Cell Types in Describing Neuronal Physiological Features

Single-cell RNA sequencing (scRNA-seq) captures detailed gene expression profiles at scale, while patch-clamp recordings measure intrinsic neuronal electrophysiological properties. Modeling the relations between these two modalities remains a challenge. Here, we compare how well electrophysiological features can be predicted by traditional transcriptomic cell type classification, representations derived from a foundational model (scGPT) pretrained on large-scale scRNA-seq datasets, ion channel-coding genes, and highly variable genes. Using paired transcriptomic and electrophysiological patch-sequencing data from 495 human neurons from neurosurgical tissue, we find that cluster-level cell type representations consistently outperform highly variable gene selection, ion channel gene selection, and context-enriched scGPT embeddings. Notably, performance varies across model architectures and initializations, and the best results are obtained by combining the outputs of separate cell type and scGPT-based models. Together, these findings suggest that traditional discrete cellular classification is highly effective in predicting physiological features. For maximum performance it can be complemented by pretrained transformer models.

neuroscience↗
bioRxiv2026

A nonlinear inhibition pathway underlying cortical responses to tuned holographic optogenetic perturbations

Optogenetics enables causal manipulation of cortical activity. Perturbation responses can be counterintuitive due to network interactions, making theory essential for predicting them. Existing approaches often rely on linear approximations, which fail for many biologically relevant perturbations. Here we develop a nonlinear theory of responses to holographic perturbations in cell-type-specific recurrent networks with structured connectivity. We fit a nonlinear model to mouse V1 data, which shows cotuned-ensemble suppression: perturbing spatially clustered neurons with similar preferred orientations yields markedly stronger short-range suppression than perturbing untuned ensembles. We show that cotuned-ensemble suppression arises from a feature-tuned, nonlinear inhibition pathway implicating somatostatin-positive (SST) interneurons. The theory predicts that cotuned ensembles suppress parvalbumin-positive (PV) neurons but facilitate SST neurons, and links the degree of cotuned-ensemble suppression or facilitation to the variance of the SST response. This framework identifies mechanisms by which nonlinear inhibition sculpts cortical dynamics and establishes a predictive basis for targeted optogenetic interventions.

neuroscience↗
bioRxiv2026

Proteomic signatures of APOE ε4 across human tissues and cell types in Alzheimers disease

The apolipoprotein E {varepsilon}4 (APOE {varepsilon}4) allele is the strongest genetic risk factor for late-onset Alzheimers disease (AD). However, the underlying molecular mechanisms remain unclear. This study included 1691 participants from the Religious Orders Study and Rush Memory and Aging Project (ROSMAP), 1226 participants from the Accelerating Medicines Partnership - Alzheimers Disease (AMP-AD) Diverse Cohorts Study, and 735 participants from the Alzheimers Disease Neuroimaging Initiative (ADNI). To characterise APOE {varepsilon}4 molecular effects, we analysed proteomic data from plasma, cerebrospinal fluid (CSF), and induced pluripotent stem cell (iPSC)-derived astrocytes and neurons, as well as transcriptomic and proteomic data from multiple brain regions. The association of APOE {varepsilon}4 with AD neuropathology was also examined. APOE {varepsilon}4 carriers shared a plasma proteomic signature enriched for immune processes, irrespective of AD diagnosis. A machine learning classifier trained on this signature discriminated APOE {varepsilon}4 carriers from non-carriers in an independent cohort using CSF proteomics. APOE {varepsilon}4 carriage was associated with higher Braak stages and Consortium to Establish a Registry for Alzheimers Disease (CERAD) score. However, only limited APOE {varepsilon}4-associated transcriptomic and proteomic changes were observed in bulk brain tissue, with poor cross-layer concordance. Proteomic analyses of iPSC-derived astrocytes and neurons further revealed cell-type-specific APOE {varepsilon}4-associated changes. APOE {varepsilon}4 is associated with a consistent proteomic signature across plasma and CSF. Its molecular effects in the brain differ across cell types, brain regions and molecular layers. These findings support the need for cell-type-resolved multi-omic studies to elucidate how APOE {varepsilon}4 confers AD risk.

neuroscience↗